The broad ‘health care’ division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead.
Global coronary stents industry forecasts to reach at US$7 billion by 2015 at a CAGR of 9.1% during the analysis period 2009-2015. The North American segment accounts for nearly 35% of the global value while Europe claims nearly 25% of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.2% driving a market value of US$2.2 billion by 2015. On a global scale, projections for drug eluting stents market value indicate nearly 65% by 2015 leaving the rest of the market to the base metal and absorbable varieties. By technology PERSE is the fastest growing market.